SCHEMBL14213302

SCHEMBL14213302

CC(=O)c1cc(C(C)(C)C)on1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
MAPK1 P28482 1/20 0.50
EGFR P00533 1/20 0.49
SMN1; SMN2 Q16637 5/20 0.47
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
MAPK14 Q16539 2/20 0.44
HPGD P15428 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
HTT P42858 2/20 0.42
PKM P14618 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
RAPGEF3 O95398 2/20 0.42
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24130013 0.86 ALDH1A1 (0.39) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1
SCHEMBL1809204 0.83 ALDH1A1 (0.50) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1
SCHEMBL9315098 0.82 ALDH1A1 (0.53) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL9315107 0.82 ALDH1A1 (0.49) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1
SCHEMBL1515627 0.82 ALDH1A1 (0.49) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL3712256 0.80 ALDH1A1 (0.48) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1
SCHEMBL18471505 0.79 ALDH1A1 (0.47) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1
SCHEMBL26795644 0.79 ALDH1A1 (0.57) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1
SCHEMBL3874355 0.77 EGFR (0.59) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1
SCHEMBL18407332 0.77 ALDH1A1 (0.56) ALDH1A1MAPK1EGFRSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120309750-A1 5-MEMBERED HETEROCYCLE DERIVATIVES AND MANUFACTURING PROCESS THEREOF ILDONG PHARM CO., LTD. (KR) 2012-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309750-A1 5-MEMBERED HETEROCYCLE DERIVATIVES AND MANUFACTURING PROCESS THEREOF CYP3A5, UGT2B7, UGT1A7 ALDH1A1 590/4885MAPK1 1492/4885EGFR 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.